Balta Bargude, Delelegn Alemayehu, Demissie Gulema, Deribe Bedilu
Hawassa University College of Medicine and Health Sciences, Hawassa, Ethiopia.
PLoS One. 2025 Apr 7;20(4):e0321306. doi: 10.1371/journal.pone.0321306. eCollection 2025.
Medication adherence refers to how closely a patient follows the prescribed timing and dosage of their treatment. Adherence to chemotherapy is particularly complex and multifaceted, and it can have a significant impact on the effectiveness of the therapy. In Ethiopia, non-adherence to chemotherapy is on the rise, but there has been limited research specifically on adherence to intravenous (IV) chemotherapy.
This study assesses IV chemotherapy adherence and associated factors among cancer patients in the Sidama Region, southern Ethiopia.
A hospital-based cross-sectional study included a purposive sample of 413 cancer patients undergoing IV chemotherapy. The Morisky Medication Adherence Scale was used to measure adherence levels. Data analysis was performed using SPSS version 26, employing descriptive statistics such as frequency distribution, mean, median, and standard deviation to describe the characteristics and magnitude of IV chemotherapy adherence. Bivariable and multivariable logistical regression analysis was conducted to identify factors associated with IV chemotherapy adherence.
The current study revealed that the overall magnitude of good adherence toward chemotherapy treatment among cancer patients was 176/413(42.6%), with a 95% CI of 38-47.9. The multivariable analysis identified several independent factors associated with IV chemotherapy adherence. These factors included being married (AOR = 3.2, 95% CI:1.3,8), employment as a government employee (AOR = 2.4,95% CI:1.3,4.5), availability of transportation (AOR = 5.5, 95% CI:2.1,14), Good social support (AOR = 2.1,95% CI:1.9,11.3) and having a curative goal of treatment (AOR = 1.7,95% CI:1.1,2.7).
In the current study, the magnitude of intravenous chemotherapy adherence among patients with cancer was low compared to published national and international findings. Possible contributing factors include marital status, employment, Transportation availability, and social support. Targeted measures are needed to improve adherence and, as a result, maximize therapeutic benefits.
药物依从性是指患者遵循规定治疗时间和剂量的程度。化疗的依从性尤其复杂且多方面,并且会对治疗效果产生重大影响。在埃塞俄比亚,化疗不依从的情况正在增加,但专门针对静脉内(IV)化疗依从性的研究有限。
本研究评估埃塞俄比亚南部锡达马地区癌症患者的静脉化疗依从性及相关因素。
一项基于医院的横断面研究纳入了413例接受静脉化疗的癌症患者的目的性样本。使用莫尔斯基药物依从性量表来测量依从水平。使用SPSS 26版进行数据分析,采用频率分布、均值、中位数和标准差等描述性统计来描述静脉化疗依从性的特征和程度。进行双变量和多变量逻辑回归分析以确定与静脉化疗依从性相关的因素。
当前研究表明,癌症患者中对化疗治疗的良好依从性总体比例为176/413(42.6%),95%置信区间为38 - 47.9。多变量分析确定了几个与静脉化疗依从性相关的独立因素。这些因素包括已婚(比值比[AOR]=3.2,95%置信区间:1.3,8)、为政府雇员(AOR = 2.4,95%置信区间:1.3,4.5)、有交通工具(AOR = 5.5,95%置信区间:2.1,14)、良好的社会支持(AOR = 2.1,95%置信区间:1.9,11.3)以及有治愈性治疗目标(AOR = 1.7,95%置信区间:1.1,2.7)。
在当前研究中,与已发表的国内和国际研究结果相比,癌症患者的静脉化疗依从性较低。可能的促成因素包括婚姻状况、就业、交通工具可用性和社会支持。需要采取针对性措施来提高依从性,从而最大化治疗益处。